What one share of Boundless Bio holds
The terms “we,” “us,” “our,” “our company,” “Boundless Bio,” “Boundless,” or the “Company” refer to Boundless Bio, Inc. unless otherwise stated or the context otherwise requires. Unless otherwise stated, references to particular years, quarters, months, or periods refer to our fiscal years ending December 31 and the associated quarters, months, and periods of those fiscal years.
Boundless Bio’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$2.86 |
|---|---|
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$2.53 |
| Cash and investments | $0.90 |
| Book value | $2.94 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | — | −$40.65 | $0.52 | −$39.05 | — | −$101.83 |
| 2024 | — | −$3.85 | $0.15 | −$3.73 | — | $6.76 |
| 2025 | — | −$2.60 | $0.02 | −$2.11 | — | $4.40 |
Common questions about Boundless Bio
How much does one share of Boundless Bio earn?
Over the last 12 months, Boundless Bio lost $2.86 for each share.
Does Boundless Bio pay a dividend?
Boundless Bio didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Boundless Bio’s book value per share?
Boundless Bio’s book value is $2.94 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Boundless Bio have?
Each share of Boundless Bio has $0.90 of cash and investments, as of June 30, 2026.
What is Boundless Bio’s free cash flow per share?
−$2.53 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.